武汉云克隆科技股份有限公司

脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体

Polyclonal Antibody to Phospholipase A2 Group VII (LpPLA2)

PLA2G7; PAF-AH; PAFAH; Lp-PLA2; LDL-PLA2; Platelet Activating Factor Acetylhydrolase,Plasma; Phospholipase A2,Group VII; LDL-associated phospholipase A2; Phospholipase A2, Lipoprotein Associated

  • 脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体产品包装(模拟)
  • 脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体产品包装(模拟)
  • 脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体IHC图
  • PAA867Mu01.jpgFigure. Western Blot; Sample: Recombinant LpPLA2, Mouse.
  • 脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体Figure. Western Blot; Sample: Lane1: Rat Serum; Lane2: Mouse Serum; Lane3: Mouse Brain Tissue.
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对LpPLA2的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别LpPLA2。

用法

Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号适用物种：Mus musculus (Mouse，小鼠)应用(仅供研究使用，不用于临床诊断！)
RPA867Mu03脂蛋白关联磷脂酶A2(LpPLA2)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA867Mu04脂蛋白关联磷脂酶A2(LpPLA2)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA867Mu01脂蛋白关联磷脂酶A2(LpPLA2)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA867Mu02脂蛋白关联磷脂酶A2(LpPLA2)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA867Mu02脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体WB; IHC; ICC; IP.
PAA867Mu03脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体WB; IHC; ICC; IP.
PAA867Mu01脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体WB; IHC; ICC; IP.
LAA867Mu81脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体(异硫氰酸荧光素标记)WB; IHC; ICC; IF.
LAA867Mu71脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体(生物素标记)WB; IHC; ICC.
SEA867Mu脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA867Mu脂蛋白关联磷脂酶A2(LpPLA2)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
Science & SportsThe effects of different intensity walking programs on serum blood lipids, high-sensitive C-reactive protein, and lipoprotein-associated phospholipase A2 in premenopausal women[ScienceDirect: S0765159710000262]
Metabolic Syndrome and Related DisordersAssociation of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease[Wiley: source]
34Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study[PubMed: 22240497]
PLoS ONEEffects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo[PubMed: PMC3759413]
China PharmacyInfluence of Tongfengtai Granules on Inflammatory Factor in Acute Gouty Arthritis Model Rats[Source]
AtherosclerosisEverolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients.[Pubmed: 23958269]
Journal of Diabetes ResearchLipoprotein-Associated Phospholipase A2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus[Hindawi: 278063]
HealthThe Role of Asymmetric Dimethylarginine and Lipoprotein Associated Phospholipase A2 in Children and Adolescents with Dyslipidemia[Scirp:Source]
Biology BulletinIn vitro lipid-lowering and fibrinolytic effects of regulatory leucine-containing glyprolines in human blood[Springer:Source]
Gynecol Endocrinol. Lipoprotein-associated phospholipase A2 and AGEs are associated with cardiovascular risk factors in women with history of gestational diabetes mellitus.[Pubmed:24397392]
Journal of Diabetes ResearchLipoprotein-Associated Phospholipase A 2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus[Pubmed:24818163]
Metabolism.Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes[Pubmed:25034387]
J Am Heart AssocEffect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients[PubMed: 26374297]
Czecho-Slovak Dermatology / Cesko-Slovenska DermatologieV[Ebscohost]
Endocrinol Metab (Seoul).Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA2 in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome[pmc:PMC4803547]
Clin Pharmacol Ther. Effect of dipyridamole on myocardial reperfusion injury: A double‐blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery[Pubmed:25773594]
Lipids in Health and DiseaseEffect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A 2 and secretory phospholipase A 2 in patients with newly …[articles:10.1186]
Acta EndocrinologicaSERUM LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN MALES WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA.[jrnl:1841098]
Biomarker for diagnosis of moyamoya disease[:]
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATIONCirculating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions[Pubmed: 32859455]
chinese neurosurgical journalCan admission lipoprotein-associated phospholipase A2 predict the symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage?[]